Literature DB >> 30561820

Serological profile of asymptomatic HCV positive patients with low level of cryoglobulins.

Umberto Basile1, Cecilia Napodano2, Krizia Pocino2, Francesca Gulli3, Stefano Angelo Santini1, Laura Todi4, Mariapaola Marino4, Gian Ludovico Rapaccini2.   

Abstract

Clinical spectrum of hepatitis C virus (HCV)-related cryoglobulinemia varies from an asymptomatic presentation to severe vasculitis and lymphoma. A recent study in HCV-negative patients suggests that low cryoglobulins (CGs) levels are responsible for severe renal and neurological complications. The aim of this study was to identify a panel of serological biomarkers associated with low levels of CGs in HCV-positive patients. We studied a population of 79 untreated patients with chronic HCV infection: 13 naïve patients without CGs; 28 patients with asymptomatic mixed cryoglobulinemia (MC) and low levels of CGs (16/28 with polyclonal type III and 12/28 with microheterogeneous type III CGs); 38 patients with symptomatic MC and high levels of type II CGs. Serum samples were collected and examined for rheumatoid factor (RF) IgG and IgM, free light chains (FLCs) and C3 and C4 complement components. We found that RF-IgG and IgM, free k chains and k+λ were increased while C4 component was reduced, both in symptomatic and asymptomatic patients. Our results suggest that, even in absence of MC symptoms, the low levels of CGs may represent a trigger of activation for immune system in course of HCV infection. The identification of a correlated biomarkers panel could improve the clinical management of these patients and pave the way for target treatment strategies.
© 2018 BioFactors, 45(3):318-325, 2019. © 2018 International Union of Biochemistry and Molecular Biology.

Entities:  

Keywords:  Cryoglobulins; HCV; RF-IgG/IgM; biomarkers; free light chains

Year:  2018        PMID: 30561820     DOI: 10.1002/biof.1485

Source DB:  PubMed          Journal:  Biofactors        ISSN: 0951-6433            Impact factor:   6.113


  2 in total

1.  Serum immunoglobulin free light chain levels in systemic autoimmune rheumatic diseases.

Authors:  F Gulli; C Napodano; M Marino; G Ciasca; K Pocino; V Basile; M Visentini; A Stefanile; L Todi; M De Spirito; G L Rapaccini; U Basile
Journal:  Clin Exp Immunol       Date:  2019-10-31       Impact factor: 4.330

2.  Significance of Anti-Nuclear Antibodies and Cryoglobulins in Patients with Acute and Chronic HEV Infection.

Authors:  Thomas Horvatits; Julian Schulze Zur Wiesch; Susanne Polywka; Gustav Buescher; Marc Lütgehetmann; Elaine Hussey; Karoline Horvatits; Sven Peine; Friedrich Haag; Marylyn M Addo; Ansgar W Lohse; Christina Weiler-Normann; Sven Pischke
Journal:  Pathogens       Date:  2020-09-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.